Browse the latest research summaries in the field of regenerative medicine for spinal cord injury patients and caregivers.
Showing 331-340 of 2,298 results
Neuroscientist, 1999 • January 1, 1999
The review discusses the inhibitory effects of CNS myelin and reactive astrocytes on axon regeneration after injury. It highlights the role of molecules like NI-35/250 in myelin and chondroitin sulfat...
KEY FINDING: Molecules derived from myelin inhibit axon outgrowth. A high-molecular-weight membrane protein (NI-35/250) has been found in rat, bovine, and human myelin as a main neurite growth inhibitory factor.
Molecular Neurobiology, 2024 • May 25, 2024
This study investigates the potential of Wnt5a-modified bone marrow mesenchymal stem cells (BMSCs) to promote recovery after spinal cord injury (SCI) by enhancing neuronal differentiation and reducing...
KEY FINDING: Wnt5a enhances neuronal differentiation of BMSCs in vitro while reducing astrocyte differentiation.
Neural Regeneration Research, 2024 • March 1, 2024
This systematic review investigates the potential of NG2 cells to differentiate into neurons in models of traumatic brain injury (TBI) and spinal cord injury (SCI). It summarizes findings from 11 sel...
KEY FINDING: NG2 cells possess an inducible neurogenic potential in animal models and in vitro, and this can be promoted by pharmacological and genetic approaches.
Regenerative Therapy, 2024 • March 15, 2024
This study analyzed the AE of 14 types of cell therapy clinical trials in human chronic spinal cord injury and showed that in 45 studies of 76 reviewed articles, 64 types of AEs in 12 categories were ...
KEY FINDING: The most common adverse events were transient backache and meningism (90%) and cord malacia (80%).
Neural Regeneration Research, 2025 • May 24, 2024
This review examines therapeutic strategies for traumatic SCI regeneration in non-human primates (NHP) and pilot studies in humans, emphasizing cell transplantation and functional biomaterials. The re...
KEY FINDING: Stem cell-based transplantation shows promise due to direct tissue replacement, neuroprotection, and support for axonal regrowth and neuronal plasticity.
NEURAL REGENERATION RESEARCH, 2025 • June 3, 2024
This study investigates the efficacy of combining Schwann cell (SC) transplantation with chondroitinase ABC (ChABC) to enhance neural repair and functional recovery following spinal cord injury (SCI) ...
KEY FINDING: Chondroitinase ABC (ChABC) treatment effectively degraded CSPGs, reduced glial response, and promoted the migration of grafted Schwann cells (SCs) in the injured spinal cord.
Biomedicines, 2021 • November 24, 2021
This study evaluated the therapeutic potential of human mesenchymal stem cells (hMSCs) and their secretome (CM) in treating Spinocerebellar Ataxia type 3 (SCA3/MJD) using a mouse model. The results sh...
KEY FINDING: A single CM administration to the cerebellum had a mild effect on the balance and motor deficits of SCA3/MJD mice.
Cell Reports Medicine, 2024 • December 17, 2024
This study reports the long-term results for a phase 1 study of neural stem cell transplantation for chronic spinal cord injury. Here, we report that all four subjects tolerated the stem cell implanta...
KEY FINDING: All four subjects tolerated the stem cell implantation procedure well, with no serious adverse events immediately following the procedure.
Stem Cell Research & Therapy, 2024 • November 20, 2024
This study introduces MRR as a rapid, label-free method for assessing the safety and quality of iPSC-derived SCPCs by measuring intracellular iron levels. The results demonstrate that MRR can effectiv...
KEY FINDING: Intracellular iron levels are significantly different between iPSCs and SCPCs, allowing MRR to distinguish between the two cell types based on T2 values.
Journal of Translational Medicine, 2024 • December 3, 2024
This study demonstrated that TET3-mediated demethylation reshapes the methylation patterns of HUCMSCs, enabling their efficient one-step conversion into OPCs and significantly reducing the time requir...
KEY FINDING: TET3 enhances HUCMSC differentiation into OPCs, evidenced by specific marker expression.